The role of digital health in respiratory diseases management: a narrative review of recent literature

TY - JOUR

T1 - The role of digital health in respiratory diseases management

T2 - a narrative review of recent literature

AU - Althobiani, Malik A

AU - Russell, Anne-Marie

AU - Jacob, Joseph

AU - Ranjan, Yatharth

AU - Ahmad, Rami

AU - Folarin, Amos A

AU - Hurst, John R

AU - Porter, Joanna C

N1 - Publisher Copyright: Copyright © 2025 Althobiani, Russell, Jacob, Ranjan, Ahmad, Folarin, Hurst and Porter.

PY - 2025

Y1 - 2025

N2 - This review provides a detailed overview of how digital health can be utilized in the management of Interstitial Lung Disease (ILD), and Chronic Obstructive Pulmonary Disease (COPD). ILD encompasses a diverse range of lung disorders characterized by inflammation and scarring of lung tissue, leading to restrictive lung physiology and impaired gas exchange, with symptoms including progressive dyspnoea, cough, and hypoxia. COPD which ranks as the third leading cause of death globally, is characterized by chronic lung inflammation causing irreversible airflow obstruction, recurrent exacerbations. While recent advances in digital health have shown promise, predicting disease progression in patients with ILD and exacerbation in patients with COPD remains challenging. This review explores the role of digital health in managing ILD and COPD, particularly focusing on telehealth and digital health technologies. Telehealth, defined broadly as the use of electronic information and telecommunications technologies in healthcare, has become increasingly relevant, especially during the COVID-19 pandemic. This review examines the role of digital health technologies in the management of ILD and COPD, with particular focus on telemedicine, and digital health tools. Remote monitoring technologies, including home spirometry and wearable devices, have demonstrated feasibility in managing respiratory diseases. However, challenges such as evidence, data reliability, varying adherence, education, and the high costs of data collection and lack of qualified clinicians present barriers for many national health systems.

AB - This review provides a detailed overview of how digital health can be utilized in the management of Interstitial Lung Disease (ILD), and Chronic Obstructive Pulmonary Disease (COPD). ILD encompasses a diverse range of lung disorders characterized by inflammation and scarring of lung tissue, leading to restrictive lung physiology and impaired gas exchange, with symptoms including progressive dyspnoea, cough, and hypoxia. COPD which ranks as the third leading cause of death globally, is characterized by chronic lung inflammation causing irreversible airflow obstruction, recurrent exacerbations. While recent advances in digital health have shown promise, predicting disease progression in patients with ILD and exacerbation in patients with COPD remains challenging. This review explores the role of digital health in managing ILD and COPD, particularly focusing on telehealth and digital health technologies. Telehealth, defined broadly as the use of electronic information and telecommunications technologies in healthcare, has become increasingly relevant, especially during the COVID-19 pandemic. This review examines the role of digital health technologies in the management of ILD and COPD, with particular focus on telemedicine, and digital health tools. Remote monitoring technologies, including home spirometry and wearable devices, have demonstrated feasibility in managing respiratory diseases. However, challenges such as evidence, data reliability, varying adherence, education, and the high costs of data collection and lack of qualified clinicians present barriers for many national health systems.

UR - http://www.scopus.com/inward/record.url?scp=86000494921&partnerID=8YFLogxK

U2 - 10.3389/fmed.2025.1361667

DO - 10.3389/fmed.2025.1361667

M3 - Review article

C2 - 40078397

SN - 2296-858X

VL - 12

SP - 1361667

JO - Frontiers in Medicine

JF - Frontiers in Medicine

M1 - 1361667

ER -